研究emicizumab在现实条件下对儿童、青少年、成人和老年血友病A患者(有或没有因子VIII (FVIII)抑制剂)的有效性

{"title":"研究emicizumab在现实条件下对儿童、青少年、成人和老年血友病A患者(有或没有因子VIII (FVIII)抑制剂)的有效性","authors":"Medical Information","doi":"10.1186/isrctn58752772","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13169,"journal":{"name":"http://isrctn.com/","volume":"66 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study to investigate the effectiveness of emicizumab under real-world conditions in paediatric, adolescent, adult and elderly participants with haemophilia A with and without Factor VIII (FVIII) inhibitors\",\"authors\":\"Medical Information\",\"doi\":\"10.1186/isrctn58752772\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13169,\"journal\":{\"name\":\"http://isrctn.com/\",\"volume\":\"66 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"http://isrctn.com/\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/isrctn58752772\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"http://isrctn.com/","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/isrctn58752772","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}